Product Description
Description: Torque’s Montor BL Tablets contain Bilastine, a second-generation H1-antihistamine and Montelukast which is a leukotriene receptor antagonist.
Pharmaceutical Dosage Form: Tablets
Route of Administration: Oral
Composition:
| Each film coated tablet contains: | ||
| Bilastine | IP | 20 mg |
| Montelukast sodium eq. to Montelukast | IP | 10 mg |
| Excipients | q.s. | |
Mechanism of Action: Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral H1 receptor antagonist affinity and no affinity for muscarinic receptors. Montelukast is an orally active compound that binds with high affinity and selectivity to the CysLT1 receptor. CysLT (cysteinyl leukotriene: LTC4, LTD4, LTE4) receptors have been correlated with the pathophysiology of asthma and allergic rhinitis
Indications: Torque’s Montor BL Tablets are indicated for the treatment of allergic rhinitis (Perennial and Seasonal).
Dosage: As directed by the physician.
Storage: Store at a temperature not exceeding 30°C, protect from light & moisture
Presentation: 10 x 1 x 10 Tablets
Side effects:
Headache
Allergic conjunctivitis
Abdominal pain/upper abdominal pain
Drowsiness
Contraindications: Torque’s Montor BL Tablets are contraindicated in patients with known hypersensitivity to the active substance or to any of the excipients.
Drug Interaction:
Ketoconazole or Erythromycin
Diltiazem
Lorazepam
Theophylline
Prednisolone
Terfenadine
Digoxin
Warfarin
